{"id":"NCT00943098","sponsor":"IBSA Institut Biochimique SA","briefTitle":"Evaluation of the Efficacy and Safety of Diclofenac HPBCD 75mg/ml in Treatment of Pain Following Dental Surgery","officialTitle":"Efficacy and Safety of a Single s.c. Diclofenac HPBCD 75mg/1ml Injection as Compared to a Single i.m. Voltarol® 75mg/3ml, in the Treatment of Acute Moderate-to-severe Post-surgical Pain Following Dental Surgery (Impacted 3rd Molar Removal).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2010-03","completion":"2010-05","firstPosted":"2009-07-22","resultsPosted":"2013-01-28","lastUpdate":"2013-01-28"},"enrollment":142,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Dental Pain"],"interventions":[{"type":"DRUG","name":"Diclofenac HPBCD s.c. 75mg/ml","otherNames":[]},{"type":"DRUG","name":"Voltarol 75mg/3ml i.m.","otherNames":[]}],"arms":[{"label":"Diclofenac HPBCD s.c. 75mg/ml","type":"EXPERIMENTAL"},{"label":"Voltarol 75mg/3ml i.m.","type":"ACTIVE_COMPARATOR"}],"summary":"The present study is aimed at demonstrating the therapeutic equivalence of diclofenac HPBCD 75mg/1ml s.c. with the marketed reference product, Voltarol® 75mg/3ml i.m. in the treatment of acute moderate-to-severe pain after dental impaction surgery.","primaryOutcome":{"measure":"Pain Intensity Difference (PID)","timeFrame":"1.5 hours","effectByArm":[{"arm":"Diclofenac HPBCD s.c. 75mg/ml","deltaMin":44.8,"sd":null},{"arm":"Voltarol 75mg/3ml i.m.","deltaMin":45.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.813"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":3,"countries":["United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":70},"commonTop":["Injection site pain","Headache","Nausea","injection site haematoma","Injection site reaction"]}}